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Abstract: Objective: To assess the FitBit FlexTM as a low-intensity, low cost physical 
activity (PA) intervention for pediatric cancer survivors (PSCs). Additionally, we aimed 
to assess the impact of social support (SS) for PA on moderate to vigorous physical 
acticity (MVPA), and the feasibility/acceptability of survivors wearing a FitBit FlexTM. It 
was hypothesized that wearing a FitBit FlexTM and increased SS would increase rates of 
MVPA/step count and that survivors and their families would report high 
feasibility/acceptability of FitBit FlexTM use. Methods: Utilizing an N-of-1 design, 
participants and one of their parents were randomized by day for 30 days to wear or not 
wear the FitBit FlexTM. SS for PA was measured using the Social Support for Exercise 
Survey. Acceptability and feasibility were assessed using a Feedback Questionnaire and 
examining protocol compliance. Results: Twelve PCSs (Mage = 13.6 years; 33% male; 
67% Caucasian) completed the study. Participants engaged in less MVPA than 
recommended. Additionally, the FitBit FlexTM intervention negatively impacted rates of 
MVPA and step counts. SS did not have an impact on rates of MVPA. Participants were 
adherent to wear time and study protocol. Acceptability and feasibility were high. 
Conclusions: Rates of PA are a concern among PCSs and interventions are needed to 
promote positive behavior change. Future research should aim to better understand the 
role that electronic devices and SS can play within this specific population to help 
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The American Cancer Society (2017) has estimated that 10,270 children in the United 
States would be diagnosed with cancer in 2017 alone, with incidence rates slowly continuing to 
rise since 1975. Among children recently diagnosed with cancer, approximately 83 percent will 
survive at least 5 years past their diagnosis date (American Cancer Society, 2014). Although these 
children survive their diagnosis, many are at risk to experience significant cancer- and treatment-
related side effects, including impairment in cardiovascular and lung functioning (Hochberg, 
Cairo, & Friedman, 2014), bone growth abnormalities (Paulino, 2004), muscle and tissue atrophy 
(Paulino, 2004), increased rates of obesity (Zhang, Kelly, Saltzman, Must, Roberts, & Parsons, 
2014), increased risk for endocrine and metabolic disorders (Tonorezos, Hudson, Edgar, Kremer, 
Sklar, Wallace, & Oeffinger, 2015; Rosen, Nguyen, & Shaibi, 2013), and neurocognitive 
problems (e.g., deficits in attention, concentration, executive functioning, processing speed, and 
working memory; Olson & Sands, 2015). Additionally, adult pediatric cancer survivors are 3 
times more likely to develop a chronic illness compared to their siblings (Oeffinger et al., 2006) 
and about 8 times more likely to die prematurely compared to matched controls (Mertens, 2008). 
These side effects inevitably result in significant increases in health care utilization 




complication will occur in about 67 percent of pediatric cancer cases requiring frequent follow-up 
care (American Academy of Pediatrics, 2009), resulting in increased health care costs. For example, 
research has shown that pediatric cancer survivors have increased rates of both out- and in-patient 
hospital visits and speak with their physicians more frequently than the general population (Rebholz 
et al., 2011). Furthermore, these rates are highest among survivors who have a history of 
neuroblastoma, Wilms tumor, Hodgkin’s lymphoma, bone sarcomas, and central nervous system 
tumors (Rebholz et al., 2011). Among radiated acute lymphoblastic leukemia survivors, research 
demonstrates increased rates of hospital visits and increased days inpatient compared to matched 
controls (Holmqvist et al., 2014). In order to combat adverse cancer- and treatment-related side 
effects, research has progressed toward identifying protective behaviors. Through this work, physical 
activity has been identified as a critical intervention for improving the general health of pediatric 
cancer survivors (Gilliam et al., 2013). 
 Although the literature is limited in child studies, there is preliminary research that supports a 
link between increased rates of physical activity and decreased health care utilization among adults 
with a chronic illness. A meta-analysis of the Chronic Disease Self-Management Program, which 
encouraged adults with a chronic illness to increase their physical activity, found a relation between 
increases in physical activity and decreases in the amount of time spent in-patient in the hospital 
(Brady et al., 2013). Among adults with diabetes, participating in physical activity has been correlated 
with about 41 percent less health care costs than matched controls (Nguyen et al., 2007). Although 
rates of health care utilization have not specifically been assessed as outcomes in physical activity 
interventions among pediatric cancer survivors, research with other disease populations is promising. 
 Importantly, several studies suggest a number of positive outcomes related to physical 
activity in pediatric cancer. Outcomes from physical activity interventions with pediatric cancer 
survivors ages 16 to 30 years old include improvements in fasting plasma insulin, homeostasis model 
of assessment-insulin resistance, supine diastolic blood pressure, metabolic syndrome, peak oxygen 
uptake, and maximal workload (Järvelä, 2012). Furthermore, pediatric cancer survivors who had 
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higher physical activity endurance also had better cardiometabolic profiles (Slater et al., 2015). 
Preliminary research has also found a promising link between participation in physical activity and 
neurocognitive improvements in pediatric brain tumor survivors (Riggs et al., in press). As a result of 
these improvements, the American Cancer Society (2015) recommends that children and adolescent 
cancer survivors participate in at least 1 hour of moderate to vigorous physical activity (MVPA) per 
day. Furthermore, these children and adolescents are specifically encouraged to participate in 
vigorous physical activity at least 3 times per week. Additionally, the National Institutes of Health 
suggest that 60 minutes of MVPA translates to approximately 10,000 to 11,700 steps per day (Tudor-
Locke et al., 2011). 
 Although physical activity has been identified as improving the health of pediatric cancer 
survivors, the adverse cancer- and treatment-related side effects these children and adolescents 
experience appear to negatively impact their rates of physical activity. When comparing rates of 
physical activity, pediatric cancer survivors participate in fewer minutes of strenuous, moderate, and 
mild physical activity than their healthy peers (Hocking, 2013; Stolley, 2010). Furthermore, less than 
50 percent of pediatric cancer survivors participate in the recommended amount of physical activity 
(Badr et al., 2013; Denmark-Wahnefried, 2005). Previous research has also found pediatric cancer 
survivors to have less exercise capacity than their healthy siblings (Miller et al., 2013). As a result of 
these findings, researchers have begun to develop interventions based on theoretical models that have 
been successful in other populations (e.g., pediatric obesity) to target behavior change in pediatric 
cancer survivors (see Riggs et al., in press; Keats & Culos-Reed, 2008; Li, 2013). 
 One such theory, Control Theory, postulates that self-management and behavioral control are 
achieved through goal setting, goal reviewing, monitoring behavior, and receiving feedback on 
behavior (Carver & Scheier, 1982). This theory suggests that individuals manage their behavior based 
on a negative feedback loop (see Figure I). The negative feedback loop is used to reduce deviation 
from a perceived comparison value. In this model, the input function represents the individual’s 
perception of their current state. The individual’s current state is then compared to a reference value. 
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If there is a discrepancy between the current state and the comparator, the individual will engage in a 
behavior, the output function, to try and reduce the discrepancy. This behavior then has an impact on 
the environment, which impacts the individual’s perception of their current state (Carver & Schier, 
1982). A recent meta-analysis exploring health behavior change found that interventions that included 
self-monitoring and at least one of the four other self-regulatory techniques from control theory were 
significantly more effective than interventions without these methods (Michie et al., 2009). 
 There are a number of interventions implemented with other populations, including healthy 
adults to reduce second hand smoke exposure in children and obese children to increase physical 
activity and reduce sedentary behaviors, that have used Control Theory techniques to aid in behavior 
change (i.e., Hovell & Hughes, 2009; Kalarchian, 2009; Steele et al., 2012). Although there are 
several interventions that utilize these methods with pediatric cancer survivors (i.e., Keats & Culos-
Reed, 2008; Li, 2013), the majority of interventions with this population do not utilize Control 
Theory methods (i.e., goal setting, goal reviewing, monitoring behavior, and receiving feedback on 
behavior; Sharkey et al., 1993). Furthermore, only a handful of studies investigating the impact of 
physical activity interventions have been completed with pediatric cancer survivors, making this an 
important area of research. 
When asked about preferred health-behavior change interventions, pediatric cancer survivors 
have expressed interest in interventions that focus on increasing physical activity compared to weight 
management or dieting (Badr et al., 2013; Denmark-Wahnefried, 2005). Pediatric cancer survivors 
have also identified a preference for less invasive opposed to more invasive interventions (i.e., mail- 
or computer-based interventions, where intervention information about physical activity is mailed to 
individuals or completed via the internet, rather than clinic-, camp-, or classroom-based interventions; 
Badr et al., 2013; Denmark-Wahnefried, 2005). Unfortunately, the majority of interventions to 
improve physical activity in pediatric cancer survivors involve more invasive and time-consuming 
approaches (i.e. Keats & Culos-Reed, 2009; Li, 2013; Sharkey et al., 1993; Takken, 2009). In 
addition, a number of interventions aimed at improving physical activity in pediatric cancer survivors 
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are implemented when survivors reach adulthood (i.e., Blaauwbroek, 2009; Jarvela et al., 2013; 
Miller, 2013). However, there may be added benefits to implementing interventions focused on 
increasing physical activity in child and adolescent pediatric cancer survivors, as research has shown 
that readiness to exercise decreases with age (Denmark-Wahnefried, 2005). 
 Stemming from Bronfenbrenner’s (1977) social-ecological model, family and friend social 
support is another key construct that influences rates of physical activity and sedentary behavior. 
Within the general population, social support has been identified as the most important predictor of 
engaging in physical activity (Dowda et al., 2009). Consistent with these findings, previous research 
has found that pediatric cancer survivors who reported higher social support for physical activity were 
more likely to participate in physical activity (Gilliam et al., 2012).  
         Thus, the overarching goal of the current study was to implement a less burdensome 
intervention focused on promoting behavior change in pediatric cancer survivors through the lense of 
Control Theory (Carver & Scheier, 1982) and the social-ecological model (Bronfenbrenner, 1977). 
Therefore, this study protocol incorporated social support for physical activity by having a parent also 
wear a FitBit FlexTM and by assessing daily social support for physical activity. In this N-of-1 
randomized control trial, pediatric cancer survivors were randomized by day to wear or not wear a 
FitBit FlexTM activity monitor. This randomization resulted in each patient experiencing 15 
Intervention days and 15 Control days. They also wore an Actigraph on their hip throughout the 30 
days of the protocol, which tracked the outcome variables (MVPA and step count). Within the context 
of Control Theory (Carver & Scheier, 1982), the goal of steps per day was the reference value, 
number of steps taken was the comparator, taking more steps was the output function, steps counted 
by the FitBit FlexTM was the impact on environment, and self-monitoring of steps acted as the input 
function (see Figure II). The N-of-1 design therefore allowed us to examine for whom the 
intervention produced behavior change and, with the daily evaluation of social support, why the 
intervention had an impact.  
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 In light of the current literature, the aims of this study were to: (1) assess the impact that 
wearing a FitBit FlexTM has on rates of MVPA and step count in pediatric cancer survivors; (2) assess 
the impact that social support for physical activity had on rates of MVPA in pediatric cancer 
survivors; and (3) assess the feasibility and acceptability of pediatric cancer survivors wearing a 









Pediatric cancer survivors, along with one of their parents, who presented to the 
University of Oklahoma Health Sciences Center (OUHSC) and owned a smartphone were eligible 
for the study. Pediatric cancer survivors were identified as all children with a past diagnosis of 
cancer who were off treatment for at least one day at the time of enrollment. Children and parents 
who were not English speaking, who had a concomitant medical or psychological diagnosis, or 
who were currently enrolled in another physical activity or weight loss intervention were 
excluded from the study. Demographic information is presented in Table I. 
Procedure 
Child-parent dyads were recruited by a research assistant during their regularly-scheduled 
appointment to the pediatric oncology clinic. At enrollment, families completed all study 
measures. Additionally, both the child and parents received a FitBit FlexTM and children were 
given an ActiGraph. Children and parents were then randomized by day for a 30-day period to 
either wear (i.e., Intervention day) or not wear (i.e., Control day) the FitBit device. This allowed 
for 15 Intervention and 15 Control days over the 30 day study period. All participants and parents 
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received a randomization text-message in the morning. Furthermore, children received a text 
message each evening with a link to the Social Support for Physical Activity Questionnaire. A 
home visit was also completed approximately 2-weeks from baseline to collect the ActiGraph and 
provide the family with another fully-charged ActiGraph. Finally, a 30-day home visit was 
completed in order to collect all study materials. At this time the child and parent completed a 
Feedback Form. This study was approved by the Institutional Review Board at OUHSC. 
Materials 
The FitBit FlexTM is a consumer-available activity monitor, which is worn on the wrist. 
The FitBit FlexTM tracks steps, distance traveled, and calories burned and automatically 
downloads this information to a smartphone application. Using the application, participants were 
able to set daily goal for steps and then track progress towards that goal by tapping directly on the 
FitBit FlexTM device or by accessing the FitBit Application on their smartphone. The FitBit 
FlexTM, in conjunction with the application, allowed for participants to engage in a number of 
activities that are consistent with Control Theory (Carver & Scheier, 1982) and believed to 
encourage behavior change, including goal setting, goal review, and self-monitoring. Of 
particular importance, the utilization of the FitBit FlexTM allowed children and parents to engage 
in these activities on a minute-to-minute feedback loop. Step data were collected from the FitBit 
Application to assess adherence to randomization. However, as the FitBit was the independent 
variable, any additional data that may have been tracked by the FitBit device was not used in data 
analysis. 
 The ActiGraph accelerometer is a device used to collect information about minutes of 
mild, moderate, and vigorous physical activity, step count, and minutes of sedentary behavior. 
The ActiGraph has been identified as a reliable and valid device when measuring these constructs 
in children (Choi, 2010; Guinhouya, 2009; Ridgers, 2012). MVPA and step count collected with 
actigraphy was used as the dependent variable in this study. ActiGraph accelerometers were 
9 
 
programmed and data was abstracted using the ActiLife Lifestyle Monitoring System software 
(V.3.2.11).  
Measures 
Demographics. A demographic form was completed by the primary caregiver inquiring 
about child and parent age, gender, date of birth, race/ethnicity, child diagnosis, diagnosis date, 
and date of cancer treatment discontinuation, household income, and parent marital status. 
 Severity of Illness Scale. The Severity of Illness Scale (SOIS; Young-Saleme & Prevatt, 
1999) is a 6-item, physician-report, Likert-type response measure used to assess the medical 
severity of symptoms associated with pediatric cancer. Item responses range from 1 to 7 and a 
Total Score is calculated by tallying each item response. Total Scores range from 6-42, with 
higher scores indicating increased severity. This measure has been shown to have good interrater 
reliability, test-retest reliability, and validity (Young-Saleme & Prevatt, 1999). Baseline SOIS 
total scores can be seen in Table I. 
Intensity of Treatment Rating Scale 2.0. The Intensity of Treatment Rating Scale 2.0 
(ITR-2; Werba, Hobbie, Kazak, Ittenbach, Reilly, & Meadows, 2007) is a physician-report scale 
used to assess the intensity of pediatric cancer treatments. Physicians identify the presence or 
absence of four treatment modalities (e.g., surgery, chemotherapy, radiation, and transplantation) 
for each patient. In addition, they rate treatment intensity based on a Likert-type scale ranging 
from 1 to 4. Level 1 treatments are identified as the “Least Intensive Treatments” and Level 4 
treatments are classified as the “Most Intensive Treatments”. Therefore, higher scores indicate 
higher intensity of treatment. Additional information is provided for each specific Level to help 
physicians classify treatment intensity (e.g., Level 1: “Surgery Only – Excluding all brain tumors, 
Germ Cell Tumors – Surgery Only, Neuroblastoma – Surgery Only, Retinoblastoma – 
Enucleation (unilateral disease) without chemotherapy, Wilms’ Tumor (Stages 1, 2)” (Werba et 
al., p. 675, 2007). The ITR-2 has been shown to have good reliability and validity (Werba et al., 
2007). Baseline ITR-2 scores can be seen in Table I. 
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Pediatric Symptom Checklist/Pediatric Symptom Checklist-Youth Report. The 
Pediatric Symptom Checklist (PSC) and the Pediatric Symptom Checklist-Youth Report (Y-PSC) 
are 35-item parent- and child-report measures, respectively, used to assess behavior problems and 
psychological functioning in children (Jellinek, Murphy, & Burns, 1986). Item options include 
“Never” (0), “Sometimes” (1), and “Often” (2). A measure total score is calculated by adding 
each item score, with total scores of 28 or greater suggesting psychological impairment for the 
PSC and a total score of 30 or greater suggesting psychological distress in the Y-PSC. For the 
PSC, a cutoff of 28 has 0.95 sensitivity and 0.68 specificity (Jellinek, Murphy, Robinson, Feins, 
Lamb, & Fenton, 1988). Additionally, the PSC has been shown to have good reliability and 
validity (Jellinek, Murphy, & Burns, 1986). These measures were included to assess baseline 
psychosocial functioning. Baseline scores for the PSC and Y-PSC can be seen in Table II. It is 
important to note that although reliability statistics would normally be documented, due to the 
small sample size of this pilot study they were not included. 
 Social Support and Exercise Survey. The Social Support and Exercise Survey (SSES) 
is a 13-item self-report questionnaire assessing both family and friend social support for engaging 
in physical activity (Sallis et al., 1987). Responses are presented in a Likert-type manner ranging 
from 1 (None) to 5 (Very often). Respondents can also select a “does not apply” option. Item 
scores are tallied, omitting questions 7 to 9, to develop total scores for both family and friends 
(e.g., Family Participation and Friend Participation), with higher scores representing more social 
support for physical activity. An additional Family Reward and Punishment subscale can also be 
calculated. Reliability and validity for the SSES are acceptable (Sallis et al., 1987). Again, due to 
the small sample size, reliability statistics were not included. 
 Feedback Form. A Study Feedback Form, a 4-item questionnaire, was completed by all 
participating children and parents in order to obtain feedback about the feasibility and 
acceptability of the study protocol. Participants were asked to identify elements of the study they 
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liked, disliked, and what they would change for a future study. Questions were open-ended to 
encourage qualitative responses. 
Overview of Analyses 
Statistics. All data were entered and analyzed using Statistical Analysis System (SAS) 
9.4. Descriptive statistics were run for patient demographic information and to evaluate baseline 
psychosocial functioning, as measured by the PCS and Y-PCS, and disease characteristics, as 
measured by the SOIS and ITR-2. In order to assess the treatment effect for MVPA and then step 
count for each participant, multiple degree-of-freedom F-tests were completed. In this analysis, 
participant 9 was used as the reference participant as they were the only participant with outcome 
data for all 30 days of enrollment. In order to evaluate for carryover effects from Intervention to 
Control days, a binary predictor variable was created to identify if the previous day was an 
Intervention or Control day. This variable was then added to the previous model to assess for an 
interaction effect. For more information about this statistical analysis, see Cushing, Walters, and 
Hoffman (2013). 
Missing Cases. Of 360 MVPA data points, 73 were missing (20.3%) and of 360 step count data 
points, 68 were missing (18.8%). This was largely due to participants failing to wear the actigraph 
(42 missing data points for both MPVA and step count), incomplete data due to the battery 
running out on the actigraph device (26 missing data points for both MPVA and step count), or 
engaging in too few minutes of wear time to validate data (5 missing data points for MVPA only). 
Using SAS 9.4, missing data were analyzed and it was determined they were missing at random 
(MAR). Therefore, multiple imputation procedures using regression with predictive mean 
matching were used to deal with missing MVPA, step count, and SSES data. Multiple 
imputations have been used to reconcile missing data in other, similar N-of-1 design studies with 
similar percentages of missing data (see Nyman et al., 2016). The participants were divided into 
three separate datasets and a total of five imputations were completed, with treatment type 
(intervention or control), protocol day (1 through 30), and the three SSES subscales used as 
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auxiliary variables. Due to a smaller number of nonmissing values for SSES for participant 14, a 
separate multiple imputation procedures using the Monte Carlo method was completed. All 









Acceptability and Feasibility 
Of the 20 eligible pediatric cancer survivors receiving follow-up care in the Jimmy 
Everest Center who were approached for the study, 70.00% enrolled in this pilot study. Of those 
participants, one participant (7.14%) discontinued the study early due to a slow internet 
connection that did not allow the FitBit device and phone application to communicate. One 
additional participant was not included in data analysis due to an irreconcilable protocol deviation 
(e.g., wearing only the FitBit FlexTM on Intervention days and only the Actigraph on Control 
days). Figure III displays detailed enrollment information.  
Actigraph monitor compliance was relatively high (79.72% over 30 days), which is 
consistent with wear-time for other studies that used waist-worn accelerometers in children and 
adolescents (see Audrey et al., 2012; Tarasenko et al., 2015). Participants were adherent to 
randomization (e.g., wearing or not wearing their FitBit FlexTM) 76.67% of the time, which is 
similar to or slightly below expectation when compared to similar studies in adult populations 
(see Cadmus-Bertram et al., 2015; Choi et al., 2016). 
Qualitative information provided on the Study Feedback Form suggested that participants 
generally enjoyed using the FitBit FlexTM. For example, several participants noted that they “liked 
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wearing the FitBit”, while another stated that the protocol was “fun” and that they “enjoyed the 
step counting.” When asked to identify aspects of the study they disliked or would change, 
participants even noted that they “didn’t like not wearing the FitBit” and were “greatly 
disappointed when not wearing FitBit.” Conversely, participants generally reported less 
favorability towards wearing the actigraph daily. Specifically, participants noted that the “belt 
[which held the actigraph] bothered [their] waist” and identified dislikes of the study as having 
“to wear the actigraph.” 
Related to completing the daily online SSES questionnaire, participants were compliant 
71.20% of the time. Futhermore, they were slightly more likely to complete the questionnaire on 
Intervention (73%) compared to Control days (69%), although this difference was not statistically 
significant. On the study feedback form, specifically related to the SSES participants noted that 
they “didn’t like surveys” and also did not appreciate “answering the same [questions] everyday.” 
Descriptive Statistics 
       Examination of participant descriptive statistics revealed that participants engaged in an 
average of 21.02 (SD = 21.67) minutes of MPVA daily on Intervention days compared to 22.63 
(SD = 25.27) minutes on Control days. Additionally, participants engaged in approximately 5173 
(SD = 3666) steps on Intervention days and 5429 (SD = 3667) steps on Control days. 
Importantly, the American Cancer Society (2015) suggests that pediatric cancer survivors engage 
in at least 60 minutes of MVPA daily. Thus, these results indicate that participants engaged in far 
less physical activity than recommended. See Figure IV for estimated daily MVPA by participant 
on Intervention and Control days and Figure V for daily rates of MVPA by participant. For step 
count by participant on Intervention and Control days see Figure VI and see Figure VII for daily 
step count by participant. 
Examination of Treatment Effect for Each Participant: MVPA 
       The heterogeneous variance model with multiple degree-of-freedom F-tests revealed an 
intervention effect, F(11,1776) = 4.76, p = <.0001, with a significant difference in minutes of 
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MVPA from Intervention (M = 20.93; SD = 13.45) to Control days (M = 23.06; SD = 14.63). An 
effect size estimate indicated that the intervention effect accounted for 0.25% of the variability in 
minutes of MVPA, suggesting a very small effect. Interestingly, these results indicated that rates 
of MVPA decreased when participants wore a FitBit FlexTM compared to when they did not wear 
a FitBit FlexTM. Individual participant MVPA on Intervention and Control days can be seen in 
Table III.  
Results identifying who revealed significant change specifically were requested through 
post-estimation commands and showed that participants 2, 3, 4, 6, 11, and 13 experienced a 
significant difference in MVPA from Intervention to Control days. Further examination of these 
results reveal that participants 2, 3, 6, and 13 engaged in fewer minutes of MVPA on Intervention 
days (M = 6.92, 10.24, 12.31, and 35.13 minutes, respectively) versus Control days (M = 10.25, 
17.87, 21.63, and 51.04 minutes, respectively), suggesting an opposite effect than hypothesized. 
Additionally, participants 4 and 11 engaged in more minutes of MVPA from Intervention (M = 
37.59 and 7.72 minutes, respectively) to Control days (M = 28.54 and 6.34 minutes, respectively). 
Therefore, while the intervention did not produce behavior change in 50% of participants, the 
intervention resulted in decreased rates of MVPA for 33.3% of participants and in increased rates 
for 16.7% of participants. A homogeneous variance model was also completed to assess for better 
fit. In this model, the heterogeneous variance model fit better than the homogeneous variance 
model, -2LL(11) = 15492.1 – 13380.1 = 2112, p < .001. 
Examining for Carryover Effects for MVPA 
        Due to the potential for a carryover of the intervention effect from Intervention to Control 
days, an omnibus F-test was run to assess for the presence of a carryover effect. Results indicated 
the absence of such an effect, F (11,1692) = 0.48, p = .92, suggesting no difference from Control 
days that followed a Control day from Control days that followed an Intervention day.  
Examination of Treatment Effect for Each Participant: Step Count 
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        A heterogeneous variance model with multiple degree-of-freedom F-tests revealed no 
intervention effect, F(11,1776) = 8.32, p = <0.0001, with a significant difference in number of 
steps from intervention (M = 4850.27; SD = 2534.78) to control days (M = 5230.91; SD = 
2786.00). An effect size estimate indicated that the intervention effect accounted for 0.30% of the 
variability in step count, indicating a very small effect. These results again indicated that 
participants took fewer steps when they wore a FitBit FlexTM compared to when they did not wear 
a FitBit FlexTM. Individual participant step counts on Intervention and Control days can be seen in 
Table IV.  
Furthermore, results identifying who revealed significant change specifically were 
requested through post-estimation commands and showed that participants 2, 3, 4, 5, 9, and 13 
experienced a significant difference in step count from Intervention to Control days. However, 
further examination of results reveal that participants 2, 3, 9, and 13 engaged in fewer steps on 
Intervention days (M = 2230.06, 2564.26, 1902.06, and 5302.26, respectively) versus Control 
days (M = 3919.97, 5397.69, 2207.93, and 7005.12, respectively), suggesting an opposite effect 
than hypothesized. Conversely, participants 4 and 5 engaged in more steps on Intervention days 
(M = 8533.85 and 8834, respectively) compared to Control days (M = 7017.92 and 6697.64, 
respectively). Again, step count data suggests that although the intervention did not impact step 
counts for 50% of participants, 33.3% of participants engaged in fewer steps on Intervention days 
and 16.7% of participants engaged in more steps in Intervention days. Finally, a homogeneous 
variance model was also completed to assess for better fit. In this model, the heterogeneous 
variance model fit better than the homogeneous variance model, -2LL(11) = 33426.2 – 32904.4 
= 521.8, p < .001. 
Examining for Carryover Effects for Step Count 
        Again, due to the potential for a carryover of the intervention effect from Intervention to 
Control days, an omnibus F-test was again run to assess for the presence of a carryover effect. 
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Results indicated the absence of such an effect, F (11,1692) = 0.34, p = .98, suggesting no 
difference from Control days that followed a Control day from Control days that followed an 
Intervention day.  
Evaluating the Impact of Social Support for Physical Activity 
 Social support for physical activity scores across participants averaged 19.63 on Control 
days and 20.67 on Intervention days (see Table V for individual participant SSES scores). 
Additionally, Figures VIII, IX, and X show daily SSES scores by participant, while also 
identifying days where participants engaged in > 60 minutes of MVPA. From these figures, there 
does not appear to be a strong relationship between social support, either from parents or from 
friends, and rates of MVPA. Specifically, on all three subscales of the SSES, Family 
Participation, Family Reward and Punishment, and Friend Participation, participants did not 
appear to report higher rates of social support on days when they engaged in higher levels of 








This is the first N-of-1 design randomized control trial pilot study to assess the effect of a 
FitBit FlexTM on rates of physical activity among pediatric cancer survivors. The aims of the 
current study were to 1) assess the impact of wearing a FitBit FlexTM on rates of MVPA and step 
count in pediatric cancer survivors; 2) assess the impact of social support for physical activity had 
on rates of MVPA in pediatric cancer survivors; and 3) assess the feasibility and acceptability of 
pediatric cancer survivors wearing a FitBit FlexTM. 
Broadly, findings from this study are consistent with the extant literature showing that 
pediatric cancer survivors generally fail to meet the physical activity guidelines suggested by the 
American Cancer Society (2015).  They also fail to meet step counts that correlate with these 
activity recommendations (Tudor-Locke et al., 2011). In combination with the potential health 
benefits of engaging in physical activity, this speaks to the importance of developing 
interventions to increase rates of physical activity among this population.  
Furthermore, this pilot study identified that using a FitBit FlexTM as a low-impact 
physical activity intervention does not appear to have the desired impact on daily rates of MVPA 
or daily step counts. Rather than encouraging increases in physical activity, the use of a FitBit 




These findings are consistent with a study by Le et al. (2016) who found nonsignificant 
differences from baseline to follow-up in a sample of young adult pediatric cancer survivors who 
were provided with a FitBit OneTM for 6 months. However, these findings are inconsistent with a 
study by Hayes and Van Camp (2015), which found increases in both step-count and MVPA in 
school-aged children who wore a FitBit device during recess. Schoenfelder and colleagues (2017) 
also found that FitBit FlexTM devices increased step counts among adolescents with attention 
deficit hyperactivity disorder. Results are also inconsistent with other studies in the adult 
literature, which have shown increased MVPA in interventions using FitBit devices (Cadmus-
Bertram et al., 2015 & Wang et al., 2015). However, the extant literature aimed at increasing 
step-counts through the use of FitBits is still inconclusive (e.g., Choi et al., 2016 & Valbuena, 
Miltenberger, & Solley, 2015).  
One explanation for the differences in findings between this study and others is that 
several studies used FitBit devices to measure step-counts and MVPA (e.g., Hayes & Van Camp, 
2015; Choi et al., 2016; Valbuena et al., 2015), which are not reliable or valid devices among 
adults (Sushames, Edwards, Thompson, McDermott, & Gebel, 2016). Additionally, there appears 
to be no research examining reliability and validity of FitBit devices among children and 
adolescents. These findings suggest further research is needed to examine the use of these types 
of devices in children and adolescents.  
There are several other potential explanations for the opposite effect than hypothesized in 
this intervention.  First, Control Theory (Carver & Scheier, 1982) is based on behavior 
modification resulting from a minute-to-minute feedback loop. Therefore, if the information 
provided in the feedback loop is inaccurate, it follows that behavior change could be variable. 
Unfortunately, as previously discussed, FitBit devices are not accurate in their step counts 
(Sushames et al., 2016). Thus, the current results may be a reflection of this lack of accuracy in 
the device. Additionally, by design, this protocol and the intervention by Le and colleagues 
(2016) included very low-impact interventions with minimal contact with or instruction from 
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study personnel. This is contrary to typical physical activity interventions which pose a much 
larger burden on participant time and resources by requiring them to attend weekly sessions and 
engage in specific physical activities for specific durations of time during session (see Riggs et 
al., in press; Keats & Culos-Reed, 2009; Li, 2013; Sharkey et al., 1993; Takken, 2009). These 
results thus suggest the use of a FitBit FlexTM alone may not be enough to produce meaningful 
behavior change and may even produce decreases in physical activity. This is consistent with the 
extant literature, where pedometers are typically used in conjunction within a larger intervention 
protocol (e.g., Cadmus-Bertram et al., 2015 & Wang et al., 2015). Finally, since a baseline 
assessment of MVPA or step count was not completed, it is possible that an overarching 
intervention effect, beginning on the first day of the intervention and continuing throughout the 
30 days, was missed. 
Interestingly, two participants did increase MVPA and step count as a result of the FitBit 
FlexTM intervention. The ability to detect these outcomes is one of the specific benefits of 
completing an N-of-1 design; although the sample was too small to draw further conclusions 
about the success of the protocol in these two participants compared to other participants enrolled 
in the study. Future studies should aim to better understand the nuances of using electronic 
devices to promote behavior change.  
Additionally, although inferential statistics could not be completed due to small sample 
size, visual representations of the data did not support a relationship between social support for 
physical activity and increases in MVPA or step count. This is inconsistent with previous 
research which has supported a relationship between these variables (Dowda et al., 2009; Gilliam 
et al., 2012) and within the broader theoretical social-ecological model (Bronfenbrenner, 1977). 
Future research should aim to identify socio-environmental stimuli that promote engagement in 
physical activity, such as social support from family and friends. These stimuli can then be 
infused into current behavioral protocols to help increase the likelihood of promoting positive 
behavior change.  
21 
 
     Acceptability and feasibility data show that a physical activity intervention such as the 
one presented here is generally well-received. One major difficulty included enrollment rates, 
which were just slightly above 50%. This was likely due to the perceived burden of daily contact 
with the researcher through text messaging and the necessity of wearing the actigraph for 30 days. 
However, once enrolled participants were generally adherent to the study protocol, despite its 
complexity. Participants also reported being pleased with the protocol and provided positive 
feedback. Specifically, participants reported enjoying the use of the FitBit FlexTM and even noted 
disappointment on control days. However, participants did not appreciate wearing the actigraph 
daily or completing daily surveys on their smartphone. Thus, suggesting electronic devices that 
link with smartphone applications, such as FitBits, show promise as a tool for increasing interest 
in behavior change interventions. Additionally, although children and teens may not enjoy daily 
questionnaires or waist-worn actigraphy, they are still generally willing to utilize these 
mechanisms for an extended period of time.  
There are several limitations for this pilot study. First, as this study had a small sample 
size and recruitment was completed at a single children’s hospital in the Midwest, results may not 
be generalizable to all pediatric cancer survivors. Additionally, again due to the preliminary 
nature of this protocol, the researcher was not blinded to participant randomization. The SSES 
was completed on the participants’ smartphone rather than a paper and pencil format. However, 
previous research has shown comparable validity to data collected in person versus online 
(Gosling, Vazire, Srivastava, & John, 2004). Finally, no baseline measure of MVPA or step count 
was completed. This may have resulted in the statistical analysis missing an effect that occurred 
at the start of the intervention and lasted throughout the study. Future protocols should aim to 
develop larger, double-blinded, randomized controlled trials, including a baseline assessment to 




In sum, pediatric cancer survivors consistently fall below physical activity recommendations that 
could help to alleviate numerous late-effects of their diagnosis. Current protocols aimed at 
producing behavior change tend to require significant facility resources in space, time, and staff. 
Additionally, they pose a burden to patients (Denmark-Wahnefried, 2005). Therefore, though this 
specific protocol did not induce increases in physical activity, the field needs to continue to strive 
towards developing interventions that are clinically useful and benefit patients without undue 
hardships. Specifically, future research should strive to understand the patient-specific 
components that allow some patients to benefit from the use of electronic monitoring while 
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Table I. Participant demographic information 
Child Characteristics (N = 12) %* 
Age; Mean (SD) 13.58 (2.15) 
Male 33.33 
Race/Ethnicity:  
     Caucasian 66.67 
     Hispanic/Latino 16.67 
     Native American 8.33 
     Other 8.33 
Diagnosis:  
     Low grade glioma 16.67 
     Optic pathway germinoma 16.67 
     Intracranial germinoma 8.33 
     Wilms’ tumor 8.33 
     Pre B acute lymphoblastic leukemia 8.33 
     Pilocytic astrocytoma spin 8.33 
     Burkitt’s lymphoma 8.33 
     Intracranial germ cell tumor 8.33 
     Medulloblastoma 8.33 
     Soft tissue tumor 8.33 
SOIS; Mean (SD) 15.00 (3.41) 
ITR-2; Mean (SD) 2.27 (0.88) 
Days off treatment; Mean (SD) 1391.56 (1289.39) 
Parent Characteristics (N = 12) %* 
Age; Mean (SD) 42.25 (6.03) 
Male 8.33 
Marital Status:  
     Married 50.00 
     Divorced 41.67 
     Single/Never Married 8.33 
Annual Household Income  
     >$60,000 58.33 
     $50,000-41,000 0.0 
     $40,000-31,000 16.67 
     $30,000-21,000 8.33 
     $20,000-10,000 16.67 





Table II. PSC and Y-PSC baseline scores 
Measure Baseline Mean (SD) 
PSC 17.45 (10.58) 
Y-PSC 16.40 (9.01) 
Note. SD = standard deviation; PSC = Pediatric Symptoms Checklist; Y-PSC = Pediatric 





Table III. Final Results Using Fixed-Effects Model with Constant (Heterogeneous) 
Variance: MPVA 
 Differences relative to participant 9 Unique effects for each participant 
Fixed effects Estimate SE t p Estimate SE t p 
Intercept 6.82 0.17 - - - - - - 
Intervention day 0.30 0.23 1.25 0.21 - - - - 
Control day         
     Participant 1 32.77 0.17 40.55 <0.05 39.59 2.07 19.12 <0.05 
     Participant 2 3.43 0.24 1.25 0.21 10.25 0.68 15.11 <0.05 
     Participant 3 11.05 2.08 15.77 <0.05 17.87 1.03 17.43 <0.05 
     Participant 4 21.72 0.70 4.91 <0.05 28.53 1.97 14.51 <0.05 
     Participant 5 27.19 1.04 10.64 <0.05 34.01 1.89 18.05 <0.05 
     Participant 6 14.81 1.97 11 <0.05 21.62 1.51 14.31 <0.05 
     Participant 7 27.01 1.89 14.37 <0.05 33.83 1.79 18.92 <0.05 
     Participant 9 -- -- -- -- 6.82 0.17 40.55 <0.05 
     Participant 11 -0.48 0.43 -1.13 0.26 6.34 0.39 16.21 <0.05 
     Participant 13 44.22 5.61 7.89 <0.05 51.04 5.60 9.11 <0.05 
     Participant 14 10.53 1.89 5.57 <0.05 17.35 1.88 9.22 <0.05 
     Participant 15 2.602 0.70 3.7 <0.05 9.42 0.68 13.79 <0.05 
Intervention day increase        
     Participant 1 0.53 2.94 0.18 0.86 0.82 2.93 0.28 0.78 
     Participant 2 -3.6271 0.99 -3.67 <0.05 -3.33 0.96 -3.47 <0.05 
     Participant 3 -7.9297 1.47 -5.4 <0.05 -7.63 1.45 -5.27 <0.05 
     Participant 4 8.7453 2.79 3.13 <0.05 9.04 2.78 3.25 <0.05 
     Participant 5 2.942 2.68 1.1 0.27 3.24 2.67 1.22 0.23 
     Participant 6 -9.6192 2.15 -4.47 <0.05 -9.32 2.14 -4.36 <0.05 
     Participant 7 -3.3613 2.54 -1.32 0.19 -3.06 2.53 -1.21 0.23 
     Participant 9 - - - - 0.30 0.24 1.25 0.21 
     Participant 11 1.082 0.60 1.8 0.07 1.38 0.55 2.5 <0.05 
     Participant 13 -16.2133 7.93 -2.05 0.04 -15.92 7.92 -2.01 <0.05 
     Participant 14 -2.1715 2.67 -0.81 0.42 -1.87 2.66 -0.7 0.48 
     Participant 15 0.6471 1.00 0.65 0.52 0.94 0.97 0.98 0.33 
Model fit         
     -2LL 133380.1 133380.1 
Note. SE = standard error; Participant 9 was used as the comparison variable and 
therefore the intercept estimate of 6.82 represents the mean minutes of MVPA for 
participant 9 on Control days. The intervention main effect shows that participant 9 had a 
nonsignificant increase to 7.13 minutes of MVPA on Intervention days (6.82 + 0.30 = 
7.13). Control day main effects for all other participants identify the difference in MVPA 
on Control days compared to participant 9. For example, participant 1 averaged 32.77 
more minutes of MVPA than participant 9 on Control days (e.g., 6.82 + 32.77 = 39.59). 
For participants except participant 9, Intervention day effects are intervention-by-
participant interactions. As such, they identify the difference in the treatment effect 
between participant 9 and each individual participant. Therefore, the average increase in 
simulated MVPA on treatment days for participant 1 was 0.35 minutes greater than  
 of MVPA for participant 9 on Control days. Themain effect shows that participant 9 had 
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participants 9 (e.g., 0.30 + 0.35 = 0.65). Taken together, participant 1 would average 





Table IV. Final Results Using Fixed-Effects Model with Constant (Heterogeneous) 
Variance: Steps 
 Differences relative to participant 9 Unique effects for each participant 
Fixed effects Estimate SE t p Estimate SE t p 
Intercept 2207.93 98.07 - - - - - - 
Intervention day -305.87 138.69 -2.21 <0.05 - - - - 
Control day         
     Participant 1 3071.72 335.29 9.16 <0.05 5279.65 320.63 16.47 <0.05 
     Participant 2 1712.04 248.34 6.89 <0.05 3919.97 228.15 17.18 <0.05 
     Participant 3 3189.76 291.35 10.95 <0.05 5397.69 274.35 19.67 <0.05 
     Participant 4 4809.99 446.41 10.77 <0.05 7017.92 435.5 16.11 <0.05 
     Participant 5 4985.6 333.4 14.95 <0.05 7193.53 318.65 22.58 <0.05 
     Participant 6 5333.8 557.55 9.57 <0.05 7541.73 548.86 13.74 <0.05 
     Participant 7 4200.77 273.57 15.36 <0.05 6408.71 255.39 25.09 <0.05 
     Participant 9 - - - - 2207.93 98.0702 22.51 <0.05 
     Participant 11 2284.68 299.15 7.64 <0.05 4492.61 282.62 15.9 <0.05 
     Participant 13 4797.19 470.7 10.19 <0.05 7005.12 460.38 15.22 <0.05 
     Participant 14 -19.5467 227.35 -0.09 0.93 2188.39 205.11 10.67 <0.05 
     Participant 15 1909.75 311.69 6.13 <.05 4117.68 295.86 13.92 <0.05 
Intervention day increase        
     Participant 1 713.17 474.18 1.5 0.13 407.31 453.44 0.9 0.37 
     Participant 2 -1384.04 351.2 -3.94 <0.05 -1689.91 322.65 -5.24 <0.05 
     Participant 3 -2527.56 412.04 -6.13 <0.05 -2833.43 387.99 -7.3 <0.05 
     Participant 4 1821.8 631.32 2.89 <0.05 1515.93 615.89 2.46 <0.05 
     Participant 5 1947.27 471.5 4.13 <0.05 1641.4 450.64 3.64 <0.05 
     Participant 6 -1160.01 788.5 -1.47 0.14 -1465.88 776.21 -1.89 0.06 
     Participant 7 67.56 386.89 0.17 0.86 -238.31 361.17 -0.66 0.51 
     Participant 9 - - - - -305.87 138.69 -2.21 <0.05 
     Participant 11 877.08 423.07 2.07 <0.05 571.21 399.69 1.43 0.16 
     Participant 13 -1396.99 665.68 -2.1 <0.05 -1702.85 651.07 -2.62 <0.05 
     Participant 14 -226.29 321.52 -0.7 0.48 -532.16 290.07 -1.83 0.07 
     Participant 15 370.73 440.8 0.84 0.40 64.8667 418.42 0.16 0.88 
Model fit         
     -2LL 32904.4 32904.4 





Table V. Social Support for Physical Activity Scale by Participant 
 Social Support for Exercise Survey 
 Family Participation Family Reward and 
Punishment 
Friend Participation 
 Intervention Control Intervention Control Intervention Control 
Participant 1 35.60 35.33 5.87 5.67 10.00 10.00 
Participant 2 14.80 13.52 3.25 3.20 10.09 10.13 
Participant 3 30.68 26.21 6.03 5.12 10.00 10.00 
Participant 4 25.79 25.81 6.28 6.16 22.88 22.89 
Participant 5 29.63 17.67 3.16 3.00 17.57 13.60 
Participant 6 11.47 10.00 3.00 3.00 10.60 10.00 
Participant 7 24.95 22.17 3.24 3.00 20.61 20.76 
Participant 9 12.40 15.57 3.00 3.00 11.95 11.64 
Participant 11 15.55 13.52 3.52 3.21 11.64 11.99 
Participant 13 17.87 17.64 4.49 4.71 13.88 13.65 
Participant 14 18.71 17.53 3.48 3.51 21.41 20.28 
Participant 15 11.45 13.40 3.11 3.27 18.97 15.76 











Note. From Carver & Schier, 1982. 
 
 











Goal for # Steps/Day 
Steps Counted with 
FitBit FlexTM 






Impact on Environment 
Disturbance 
Comparator 
Self-Monitoring Take More Steps 
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Note. N = number of patients. 
 
  
Potentially eligible patients attending 
follow-up session in clinic (N = 47) 
Patients unable to be 
contacted (N = 12) 
Patients declined 
(N = 6) 
Patients enrolled 
(N = 14) 
Ineligible patients 
(N = 15) 
Eligible patients 
(N = 20) 
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Figure IV. Estimated MVPA on Intervention and Control Days by Participant 
 




















Figure V. Daily MVPA by Participant 
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